- Home
- Publications
- Publication Search
- Publication Details
Title
MYCN Function in Neuroblastoma Development
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-27
DOI
10.3389/fonc.2020.624079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Target gene-independent functions of MYC oncoproteins
- (2020) Apoorva Baluapuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MYCN amplification and ATRX mutations are incompatible in neuroblastoma
- (2020) Maged Zeineldin et al. Nature Communications
- N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
- (2020) Britta Tjaden et al. Scientific Reports
- Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
- (2020) Federica Zito Marino et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors
- (2020) Ting Tao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lineage-restricted sympathoadrenal progenitors confer neuroblastoma origin and its tumorigenicity
- (2020) Chia-Lung Yang et al. Oncotarget
- Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
- (2019) John Inge Johnsen et al. Frontiers in Molecular Neuroscience
- Mechanisms of the Metabolic Shift during Somatic Cell Reprogramming
- (2019) Ken Nishimura et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Spatiotemporal structure of cell fate decisions in murine neural crest
- (2019) Ruslan Soldatov et al. SCIENCE
- Functions of p53 in pluripotent stem cells
- (2019) Xuemei Fu et al. Protein & Cell
- ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry
- (2019) Lu Wang et al. Nature Communications
- p53: emerging roles in stem cells, development and beyond
- (2018) Abhinav K. Jain et al. DEVELOPMENT
- Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma
- (2018) Rhamy Zeid et al. NATURE GENETICS
- Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma
- (2018) Laura Kerosuo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell death-based treatment of neuroblastoma
- (2018) Kadri Valter et al. Cell Death & Disease
- MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to an ROS augmenting agent
- (2018) Tingting Wang et al. Cell Death & Disease
- The Expanding World of N-MYC–Driven Tumors
- (2018) David S. Rickman et al. Cancer Discovery
- ALK in Neuroblastoma: Biological and Therapeutic Implications
- (2018) Ricky Trigg et al. Cancers
- Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma
- (2018) Hiroyuki Yoda et al. CANCER RESEARCH
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- MYCN induces neuroblastoma in primary neural crest cells
- (2017) R R Olsen et al. ONCOGENE
- MYC: Master Regulator of Immune Privilege
- (2017) Stephanie C. Casey et al. TRENDS IN IMMUNOLOGY
- Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle
- (2017) Gabriele Büchel et al. Cell Reports
- The role of the ALK receptor in cancer biology
- (2016) B. Hallberg et al. ANNALS OF ONCOLOGY
- Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State
- (2016) Wen Gu et al. Cell Stem Cell
- A new look at the ALK gene in cancer: copy number gain and amplification
- (2016) Federica Zito Marino et al. Expert Review of Anticancer Therapy
- Energy metabolism in the acquisition and maintenance of stemness
- (2016) Clifford D.L. Folmes et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells
- (2016) Mengling Liu et al. Cell Reports
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
- (2015) Robert W. Schnepp et al. CANCER CELL
- TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma
- (2015) Abdelkader Selmi et al. CANCER LETTERS
- Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation
- (2015) Alex J. Bott et al. Cell Metabolism
- ERRs Mediate a Metabolic Switch Required for Somatic Cell Reprogramming to Pluripotency
- (2015) Yasuyuki S. Kida et al. Cell Stem Cell
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- What is an adult stem cell?
- (2015) H. Clevers SCIENCE
- Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells
- (2015) Ana Sofia Rodrigues et al. PLoS One
- Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo
- (2015) Zaowen Chen et al. NEOPLASIA
- A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
- (2014) K Althoff et al. ONCOGENE
- Environmental factors unveil dormant developmental capacities in multipotent progenitors of the trunk neural crest
- (2013) Juliana M. Coelho-Aguiar et al. DEVELOPMENTAL BIOLOGY
- Setting appropriate boundaries: Fate, patterning and competence at the neural plate border
- (2013) Andrew K. Groves et al. DEVELOPMENTAL BIOLOGY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
- (2013) Andrew S Lee et al. NATURE MEDICINE
- HIF1α Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1-3 and PKM2
- (2013) Alessandro Prigione et al. STEM CELLS
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
- (2012) Fredrik J. Swartling et al. CANCER CELL
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
- (2012) Guoliang Qing et al. CANCER CELL
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Metabolic Plasticity in Stem Cell Homeostasis and Differentiation
- (2012) Clifford D.L. Folmes et al. Cell Stem Cell
- HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition
- (2012) Wenyu Zhou et al. EMBO JOURNAL
- LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
- (2012) Jan J Molenaar et al. NATURE GENETICS
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
- (2011) Fionnuala Morrish et al. CELL CYCLE
- Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
- (2011) Clifford D.L. Folmes et al. Cell Metabolism
- MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells
- (2011) L Gu et al. ONCOGENE
- p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
- (2010) L. Chen et al. CANCER RESEARCH
- Combinatorial Regulation of Neuroblastoma Tumor Progression by N-Myc and Hypoxia Inducible Factor HIF-1
- (2010) G. Qing et al. CANCER RESEARCH
- High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
- (2010) J. Carr-Wilkinson et al. CLINICAL CANCER RESEARCH
- myc maintains embryonic stem cell pluripotency and self-renewal
- (2010) Natalia V. Varlakhanova et al. DIFFERENTIATION
- Pleiotropic role for MYCN in medulloblastoma
- (2010) F. J. Swartling et al. GENES & DEVELOPMENT
- miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
- (2010) Alexander Swarbrick et al. NATURE MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- MYCN Promotes the Expansion of Phox2B-Positive Neuronal Progenitors to Drive Neuroblastoma Development
- (2009) Goleeta Alam et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeted Molecular Therapy for Neuroblastoma: The ARF/MDM2/p53 Axis
- (2009) Eugene Kim et al. JNCI-Journal of the National Cancer Institute
- N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b
- (2009) Rebecca Cotterman et al. PLoS One
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Generation of Human Induced Pluripotent Stem Cells in the Absence of ExogenousSox2
- (2009) Wenlin Li et al. STEM CELLS
- Distinct Thresholds Govern Myc's Biological Output In Vivo
- (2008) Daniel J. Murphy et al. CANCER CELL
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- (2008) Frank Westermann et al. GENOME BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started